Condition
Recurrent Cervical Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Cervical Cancer clinical trials that are recruiting, at sites in 4 countries (most in Belarus (1), Poland (1), China (1)). By phase: Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Recurrent Cervical Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer (REGYNERA-tion) Registry | — | Zamość, Lublin Voivodeship | Recruiting | Jun 24, 2026 |
| PD-1 versus PD-L1 immunotherapy combined with chemotherapy, with or without bevacizumab, for advanced cervical cancer. | Phase 2/3 | Minsk, Lesnoy | Recruiting | Mar 16, 2026 |
| SHR-A2102 versus investigator's choice chemotherapy for recurrent or metastatic cervical cancer after platinum and PD-(L)1 therapy | Phase 3 | Guangzhou, Guangdong | Recruiting | Feb 18, 2026 |
| Understanding cervical cancer treatment and characteristics in Italy | — | Bologna, Bologna and 10 other locations | Recruiting | Jan 13, 2025 |
All recruiting trials (4)
-
Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer (REGYNERA-tion) Registry
This registry tests how reirradiation and total ablative strategies are used in real-world care for adults with recurrent gynecologic cancers and tracks outcomes to see what happens after these treatments.
-
PD-1 versus PD-L1 immunotherapy combined with chemotherapy, with or without bevacizumab, for advanced cervical cancer.
This trial tests whether giving PD-1 or PD-L1 immunotherapy alongside chemotherapy, with or without bevacizumab, helps adults with metastatic, persistent, or recurrent cervical cancer.
-
SHR-A2102 versus investigator's choice chemotherapy for recurrent or metastatic cervical cancer after platinum and PD-(L)1 therapy
This trial tests whether SHR-A2102 works better than standard chemotherapy for people with recurrent or metastatic cervical cancer whose disease progressed after platinum-based chemotherapy and PD-(L)1 inhibitors.
-
Understanding cervical cancer treatment and characteristics in Italy
This study looks at how patients in Italy with advanced or recurring cervical cancer are treated and what their experiences are like.
Related topics
Quick answers
How many Recurrent Cervical Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Belarus (1 trial), Poland (1 trial), China (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.